Inflammatory Response to Hyperoxemic and Normoxemic Cardiopulmonary Bypass in Acyanotic Pediatric Patients

World Journal for Pediatric and Congenital Heart Surgery

Volumn 5, Issue 4, 2014, Pages 541-545

  Kagawa, Hiroshi ^a   Morita, Kiyozo ^a   Uno, Yoshimasa ^a   ko, Yoshihiro ^a   Matsumura, Yoko ^a   Kinouchi, Katsushi ^a   Hashimoto, Kazuhiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acyanotic pediatric patients; cardiopulmonary bypass; hyperoxemia; normoxemia

Indexed keywords

CREATINE KINASE MB; ELASTASE; ENDOTHELIN 1; F2 ISOPROSTANE; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; OXYGEN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTERIAL GAS; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; FEMALE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPEROXEMIA; HYPOTHERMIA; INFANT; INFLAMMATION; MALE; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR ACCESS; ADVERSE EFFECTS; BLOOD; COMPLICATION; DOUBLE BLIND PROCEDURE; HEART SEPTAL DEFECTS, VENTRICULAR; HEART SURGERY; HYPEROXIA; HYPERTENSION, PULMONARY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; HYPEROXIA; HYPERTENSION, PULMONARY; INFANT; OXYGEN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84925883664     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135114551029     Document Type: Article

References (15)

1. Bulutcu FS, Bayindir O, Polat B, Yalcin Y, öZbek U, Cakali E. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children? J Cardiothorac Vasc Anesth. 2002; 16 (3): 330–333.
2. Ihnken K, Winkler A, Schlensak C, et al. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg. 1998; 116 (2): 327–34.
3. Allen BS, Rahman S, Ilbawi MN, et al. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg. 1997; 64 (5): 1381–1387.
4. Kagawa H, Morita K, Nagahori R, Shinohara G, Kinouchi K, Hashimoto K. Prevention ischemia/reperfusion-induced pulmonary dysfunction after cardiopulmonary bypass with terminal leukocyte-depleted lung reperfusion. J Thorac Cardiovasc Surg. 2010; 139 (1): 174–180.
5. Ihnken K, Morita K, Buckberg GD, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: without aortic clamping. VI. Counteraction of oxidant damage by exogenous antioxidants: N-(2-mercaptopropionyl)-glycine and catalase. J Thorac Cardiovasc Surg. 1995; 110 (4 pt 2): 1212–1220.
6. Morita K, Ihnken K, Buckberg GD, Matheis G, Sherman MP, Young HH. Studies of hypoxemic/reoxygenation injury: with aortic clamping. X. Exogenous antioxidants to avoid nullification of the cardioprotective effects of blood cardioplegia. J Thorac Cardiovasc Surg. 1995; 110 (4 pt 2): 1245–1254.
7. Buckberg GD. Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc Surg. 1995; 110 (4 pt 2): 1164–1170.
8. Pinheiro JM, Pitt BR, Gillis CN. Roles of platelet-activating factor and thromboxane in group B Streptococcus-induced pulmonary hypertension in piglets. Pediatr Res. 1989; 26 (5): 420–424.
9. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991; 84 (6): 2280–2285.
10. Hiramatsu T, Imai Y, Kurosawa H, et al. Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure. Ann Thorac Surg. 2002; 73 (3): 861–865.
11. Friedman M, Sellke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994; 90(5 pt 2): II262–II268.
12. Anderson KJ, Harten JM, Booth MG, Kinsella J. The cardiovascular effects of inspired oxygen fraction in anaesthetized patients. Eur J Anaesthesiol. 2005; 22 (6): 420–425.
13. Pryor KO, Fahey TJ III, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA. 2004; 291 (1): 79–87.
14. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990; 99 (5): 873–877.
15. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest. 1994; 93 (6): 2658–2666.